STAT3 and glioblastoma: By codelivery with the siRNA target at the oncogenic and tolerogenic signal transducer and activator of transcription 3 (STAT3), the TMZ-loaded nano-micelles (siRNAmicelle@TMZ) achieved efficient therapeutic effects in TMZ-resistant GBM animal models (Figure 1).